Last year, Sir Keir Starmer signed a landmark deal with Donald Trump, committing the UK to spend more on American medicines in return for zero tariffs and better access to cutting-edge drugs.
But now, analysis by the Nuffield Trust, shared with Channel 4 News, suggests the deal could divert resources away from the frontline, costing the NHS 10,000 new staff by 2028.
And there’s another problem: many US medicines are so expensive that, even under the deal, the NHS is still unable to afford them.